Search Our Website:
Barbara A. Binzak Blumenfeld, Ph.D.
BIPC Logo

Barbara A. Binzak Blumenfeld, Ph.D.

Shareholder

FDA & Biotechnology Section Co-Chair

Washington, DC
 
 
 
  • Counseled clients on Medicare/Medicaid drug and device issues, including healthcare common procedure coding system (HCPCS) and drug coverage matters.
  • Counseled clients on investigational new drug application (IND) and biologics license application (BLA) requirements for biologic products, such as stem cells.